Nexpoint Asset Management’s AbbVie ABBV Stock Holding History

Nexpoint Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7,000	Closed	-$755K	–	219
2021 Q3	$755K	Sell	7,000 -8,000	-53%	-$914K	0.13%	79
2021 Q2	$1.69M	Buy	15,000 +5,000	+50%	+$563K	0.37%	42
2021 Q1	$1.08M	Sell	10,000 -4,000	-29%	-$428K	0.28%	55
2020 Q4	$1.5M	Sell	14,000 -4,000	-22%	-$384K	0.49%	52
2020 Q3	$1.58M	Buy	18,000 +4,000	+29%	+$377K	0.36%	55
2020 Q2	$1.38M	Buy	14,000 +4,000	+40%	+$352K	0.31%	61
2020 Q1	$762K	Sell	10,000 -5,000	-33%	-$426K	0.14%	98
2019 Q4	$1.33M	Hold	15,000	–	–	0.1%	118
2019 Q3	$1.14M	Buy	+15,000	New	+$1.03M	0.07%	190

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Nexpoint Asset Management's ABBV Position: Q4 2021 in Review

Nexpoint Asset Management sold out of AbbVie (ABBV) in Q4 2021, closing a stake of 7,000 shares — an estimated $755K sold.

Nexpoint Asset Management first reported a position in ABBV in Q3 2019 and held it in 9 quarters. The position peaked at $1.69M in Q2 2021. 2,981 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.

Nexpoint Asset Management reported no remaining AbbVie position as of Q4 2021 after selling out during the quarter.
Nexpoint Asset Management sold 7,000 AbbVie shares in Q4 2021, an estimated $755K.
Nexpoint Asset Management first reported a position in AbbVie in Q3 2019 and held it in 9 quarters.
Nexpoint Asset Management's AbbVie position peaked at $1.69M in Q2 2021.
2,981 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.

Based on Nexpoint Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.